Form 4 for NSPR InspireMD, Inc.
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0001493152-25-001734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-10 | 2025-01-07 | NSPR | Verta Patrick | EVP Clinical, Medical Affairs | A - Grant | $0.00 | +83.1K | 311.5K | +36% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Verta Patrick | EVP Clinical, Medical Affairs | A - Grant | $0.00 | +37.9K | 117.3K | +48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | A | A | 83,072 | $0.00 | 311,532 | D | — | — | (F1) These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2025-01-07 | A | A | 37,933 | $0.00 | 117,281 | D | $2.71 · — to 2035-01-07 | 37,933 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |